Uterine Serous Carcinoma
5 clinical trials · Condition
◉ Watch Uterine Serous Carcinoma
| Record | Firm | Date |
|---|---|---|
| A Study of Azenosertib (ZN-c3) in Women With Recurrent or Persistent Uterine Serous Carcinoma (NCT04814108) | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc | 2021-07-28 |
| A Study of Adavosertib as Treatment for Uterine Serous Carcinoma (NCT04590248) | AstraZeneca | 2020-11-30 |
| Trial of Maintenance With Niraparib- Uterine Serous Carcinoma (NCT04080284) | Northwell Health | 2019-12-30 |
Track Uterine Serous Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.